Front Row Advisors’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3K | Sell |
144
-96
| -40% | -$7.51K | ﹤0.01% | 358 |
|
|
2025
Q1 | $17.4K | Hold |
240
| – | – | 0.01% | 304 |
|
|
2024
Q4 | $17.8K | Hold |
240
| – | – | 0.01% | 308 |
|
|
2024
Q3 | $15.8K | Hold |
240
| – | – | 0.01% | 317 |
|
|
2024
Q2 | $22.2K | Hold |
240
| – | – | 0.01% | 401 |
|
|
2024
Q1 | $22.9K | Hold |
240
| – | – | 0.01% | 391 |
|
|
2023
Q4 | $18.3K | Hold |
240
| – | – | 0.01% | 271 |
|
|
2023
Q3 | $16.6K | Hold |
240
| – | – | 0.01% | 420 |
|
|
2023
Q2 | $23K | Hold |
240
| – | – | 0.01% | 346 |
|
|
2023
Q1 | $20K | Buy |
+240
| New | +$20K | 0.01% | 374 |
|
|
2022
Q4 | – | Sell |
-240
| Closed | -$20K | – | 897 |
|
|
2022
Q3 | $20K | Hold |
240
| – | – | 0.01% | 380 |
|
|
2022
Q2 | $23K | Hold |
240
| – | – | 0.01% | 356 |
|
|
2022
Q1 | $28K | Hold |
240
| – | – | 0.01% | 337 |
|
|
2021
Q4 | $31K | Hold |
240
| – | – | 0.01% | 332 |
|
|
2021
Q3 | $27K | Hold |
240
| – | – | 0.01% | 351 |
|
|
2021
Q2 | $28K | Hold |
240
| – | – | 0.01% | 348 |
|
|
2021
Q1 | $20K | Hold |
240
| – | – | 0.01% | 403 |
|
|
2020
Q4 | $22K | Hold |
240
| – | – | 0.01% | 366 |
|
|
2020
Q3 | $20K | Sell |
240
-372
| -61% | -$31K | 0.01% | 380 |
|
|
2020
Q2 | $42K | Sell |
612
-375
| -38% | -$25.7K | 0.03% | 238 |
|
|
2020
Q1 | $72K | Buy |
987
+747
| +311% | +$54.5K | 0.05% | 172 |
|
|
2019
Q4 | $19K | Hold |
240
| – | – | 0.01% | 337 |
|
|
2019
Q3 | $18K | Hold |
240
| – | – | 0.01% | 337 |
|
|
2019
Q2 | $15K | Hold |
240
| – | – | 0.01% | 361 |
|
|
2019
Q1 | $15K | Buy |
+240
| New | +$15K | 0.01% | 374 |
|